Vontobel Holding Ltd. Boosts Stock Position in DaVita Inc. (NYSE:DVA)

Vontobel Holding Ltd. lifted its position in DaVita Inc. (NYSE:DVA) by 17.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,243 shares of the company’s stock after buying an additional 329 shares during the quarter. Vontobel Holding Ltd.’s holdings in DaVita were worth $368,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of DVA. Blue Trust Inc. raised its holdings in shares of DaVita by 58.6% in the 2nd quarter. Blue Trust Inc. now owns 211 shares of the company’s stock valued at $29,000 after buying an additional 78 shares during the period. Family Firm Inc. purchased a new stake in DaVita during the 2nd quarter worth about $43,000. Versant Capital Management Inc increased its holdings in DaVita by 90.6% during the 2nd quarter. Versant Capital Management Inc now owns 326 shares of the company’s stock worth $45,000 after purchasing an additional 155 shares during the period. Friedenthal Financial purchased a new stake in DaVita during the 2nd quarter worth about $48,000. Finally, Point72 Hong Kong Ltd purchased a new stake in DaVita during the 2nd quarter worth about $68,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. UBS Group upped their price target on DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Truist Financial upped their price target on DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a report on Monday, October 7th. TD Cowen upped their price target on DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a report on Wednesday, July 24th. Finally, Bank of America upped their price objective on DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a research report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $159.00.

Insider Activity at DaVita

In related news, insider Kathleen Alyce Waters sold 7,857 shares of the company’s stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total value of $1,148,771.97. Following the completion of the sale, the insider now directly owns 83,011 shares of the company’s stock, valued at $12,137,038.31. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other DaVita news, insider Kathleen Alyce Waters sold 7,857 shares of the stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the completion of the sale, the insider now directly owns 83,011 shares of the company’s stock, valued at approximately $12,137,038.31. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Michael David Staffieri sold 9,539 shares of the stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $150.03, for a total value of $1,431,136.17. Following the sale, the chief operating officer now directly owns 241,945 shares of the company’s stock, valued at $36,299,008.35. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 173,482 shares of company stock valued at $27,387,069 in the last three months. 2.00% of the stock is currently owned by company insiders.

DaVita Trading Up 1.0 %

NYSE:DVA opened at $163.16 on Wednesday. The stock has a 50-day simple moving average of $157.10 and a 200-day simple moving average of $144.89. The stock has a market cap of $14.31 billion, a P/E ratio of 18.54, a P/E/G ratio of 0.93 and a beta of 0.87. DaVita Inc. has a 1 year low of $75.47 and a 1 year high of $168.50. The company has a debt-to-equity ratio of 9.94, a quick ratio of 1.12 and a current ratio of 1.16.

DaVita (NYSE:DVA) last announced its earnings results on Tuesday, August 6th. The company reported $2.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.47 by $0.12. The firm had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.15 billion. DaVita had a return on equity of 77.00% and a net margin of 6.86%. The business’s revenue was up 6.2% on a year-over-year basis. During the same period in the prior year, the firm earned $2.08 EPS. As a group, analysts anticipate that DaVita Inc. will post 9.99 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.